For the twelve months ended Sep 27, 2026, TrueBlue Inc. reported $1.78B of revenue and -$45.45M of net income.
TBI revenueQ3 2026$520.74M
- Quarter YoY
- +20.7%
- QoQ
- +17.5%
- FY YoY
- +3.1%
- 5Y CAGR
- -2.6%
- 10Y CAGR
- +16.4%
TBI revenue was $520.74M in fiscal Q3 2026 (ended Sep 27, 2026), up 20.7% from a year earlier and up 17.5% from the prior quarter. For the full fiscal 2025 it was $1.62B, up 3.1% from fiscal 2024. Compound annual growth was -2.6% over 5 years and +16.4% over 10 years. It rose in 4 of the last 10 fiscal years.
TBI net incomeQ3 2026$9.24M
TBI net income was $9.24M in fiscal Q3 2026 (ended Sep 27, 2026), compared with -$1.92M a year earlier. For the full fiscal 2025 it was -$47.96M, compared with -$125.75M in fiscal 2024.
TBI EPSQ3 2026$0.28
TBI diluted EPS was $0.28 in fiscal Q3 2026 (ended Sep 27, 2026), compared with -$0.06 a year earlier. For the full fiscal 2025 it was -$1.61, compared with -$4.17 in fiscal 2024.
TBI free cash flowQ3 2026-$28.25M
TBI free cash flow was -$28.25M in fiscal Q3 2026 (ended Sep 27, 2026), compared with -$23.38M a year earlier. For the full fiscal 2025 it was -$73.72M, compared with -$41.21M in fiscal 2024.
Source: XBRL data TrueBlue Inc. files with the SEC, latest filing dated Nov 4, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.
* Worked out from the filings rather than stated in them: Q4 is the full year less the first nine months.
Per-share figures are as filed. The filings show no stock split in these periods.
EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.